Compliance monitoring device agreement

Patients forgetting to take their medicine are estimated to cost pharmaceutical companies around $30 billion (?24.9 bn) annually, as well as additional costs related to healthcare providers, the government and society in general.

The companies have signed the agreement to develop an electronic device that will be used in clinical studies designed to register if patients take their medication correctly – and thereby measure patient compliance. Details of the agreement are confidential.